Over-expression of EpCAM reportedly correlates with biological aggressiveness and poor prognosis in CRC [126], possibly by promoting tumour immune evasion by strongly favouring T-helper cell type 2 (Th2) development that promotes growth of EpCAM-expressing tumors [127]. This evidence concerns the gene EPCAM and colorectal carcinoma.